PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 34: Articles 16501-17000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. 36 month progress report and workplan for year IV: October 1987 to September 1988: continuation and expansion of family planning operations research in Zaire.
  2. 60 years of contraception. A personal history of the progress in contraception during the past 60 years.
  3. Acceptability and side effects of a new combined oral contraceptive containing ethinylestradiol and gestodene. [Acceptabilite et effets secondaires d'un nouveau contraceptif oral a base d'ethinylestradiol et gestodene.]
  4. Access to birth control: a world assessment.
  5. Access to birth control: a world assessment. [Press Release]
  6. Adhesion of group B-Streptococcus to a polyethylene intrauterine contraceptive device.
  7. The adjusted contraceptive score (ACS) improves the overall performance of behavioural and barrier contraceptive methods.
  8. Adnexal actinomycosis in a woman using an intrauterine contraceptive device (IUD) [Promienica przydatkow u kobiety z wkladka wewnatrzmaciczna (IUD)]
  9. Adolescent abstinence: a guide for family planning professionals.
  10. Adolescent cognitive and contraceptive behaviors.
  11. The adolescent facing contraceptive problems. [L'adolescente di fronte ai problemi contraccettivi.]
  12. Adolescent fertility and contraceptive use in Mexico.
  13. Adolescent religiosity and contraceptive usage.
  14. Adolescents and birth control: a study of oral contraceptive use.
  15. Adolescents' compliance with the use of oral contraceptives.
  16. Advantage of desogestrel containing pill in oral contraception: influence on blood lipids and LCAT activity.
  17. Advantages and disadvantages of pregnancy and contraception: teenagers' perception.
  18. Adverse long-term effects of oral contraceptives: a review.
  19. AID's commitment to family planning and child survival programs.
  20. AIDS (acquired immune deficiency syndrome), family planning and well woman services: provisional guidelines from the Family Planning Association and the National Association of Family Planning Doctors.
  21. AIDS and family planning clinics: confronting the crisis.
  22. An AIDS curriculum for family planning workers in Africa: need, design, and plans for field testing.
  23. AIDS curriculum unit for nurses and nurse midwives in family planning.
  24. AIDS--of importance to family planning workers throughout the world.
  25. Airway responsiveness to methacholine during the natural menstrual cycle and the effect of oral contraceptives.
  26. Allergy to spermicidal lubricant in a contraceptive.
  27. Alternative approaches to the development of family planning programmes, report on a WHO study.
  28. American teens and birth control: commentary [editorial]
  29. Analogous features of cold-promoted activation and contact system activation in human plasmas: the role of cryptic soluble surfaces in asthma, oral contraception and pregnancy.
  30. An analysis of the cost effectiveness of the family planning program of the Mexican Institute of Social Security. [Analisis del costo beneficio del programa de planificacion familiar del Instituto Mexicano del Seguro Social.]
  31. An analysis of the relationship between the values of sexual regulation, male dominance, and motherhood, and Mexican-American women's attitudes, knowledge, and usage of birth control.
  32. Anesthesiology in female voluntary surgical contraception. [Anestesiologia em anticoncepcao cirurgica voluntaria feminina.]
  33. Oral contraceptive use and the risk of breast cancer [letter]
  34. Oral contraceptive use and the risk of breast cancer [letter]
  35. Oral contraceptive use and the risk of breast cancer [letter]
  36. Oral contraceptive use and the risk of breast cancer. [Authors' reply] [letter]
  37. Oral contraceptive use and urinary-tract infections. [Answer to question]
  38. Oral contraceptive user guide.
  39. Oral contraceptive-induced changes in plasma lipids: do they have any clinical relevance?
  40. Oral contraceptives and breast cancer [letter]
  41. Oral contraceptives and breast cancer [letter]
  42. Oral contraceptives and breast cancer [letter]
  43. Oral contraceptives and breast cancer [letter]
  44. Oral contraceptives and breast cancer [letter]
  45. Oral contraceptives and breast cancer [letter]
  46. Oral contraceptives and breast cancer [letter]
  47. Oral contraceptives and breast cancer.
  48. Oral contraceptives and breast cancer.
  49. Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth.
  50. Oral contraceptives and breast cancer. [Reply] [letter]
  51. Oral contraceptives and dysmenorrhea.
  52. Oral contraceptives and malignant non-genital tumors.
  53. Oral contraceptives and neoplasia: 1987 update.
  54. Oral contraceptives and their minor side effects: comparison of three low-dose estroprogestinic combinations. [Contraccettivi orali ed effetti collaterali minori: confronto fra tre estroprogestinici a basso dosaggio.]
  55. Oral contraceptives and uterine cancer.
  56. Oral contraceptives in the United States: trends in content and potency.
  57. Oral contraceptives reduce total protein S, but not free protein S.
  58. Oral contraceptives.
  59. Oral contraceptives. Who, which, when, and why?
  60. Oral contraceptives: clinical pharmacology, formulation, choice of preparation. [Orale Kontrazeptiva: klinische Pharmakologie, Zusammensetzung, Praparatewahl.]
  61. Oral contraceptives: the benefits and the cardiovascular risks.
  62. Oral contraceptives; a review of risks, benefits, and indications for use.
  63. Oral-contraceptive use and the risk of breast cancer [letter]
  64. Oral-contraceptive use and the risk of breast cancer [letter]
  65. Annual report: Family Planning International Assistance, 1986.
  66. Anti-oestrogen antibodies in users of oral contraceptives and in patients with systemic lupus erythematosus.
  67. Anti-prostaglandins in therapy for side effects of intrauterine contraceptive devices. [Rahim ici kontraseptif araclarin yan etkilerinin tedavisinde anti-prostaglandinler.]
  68. Antibiotic administration and oral contraceptive failure. A drug interaction to note.
  69. Antiviral activity of a chemical contraceptive (nonoxynol-9) [Attivita antivirale di un contraccettivo chimico (nonoxynol-9)]
  70. Application of the assays for progesterone and estradiol in saliva in family planning research.
  71. Appointments for adolescent pregnancy and family planning: the effects of delays in providing services.
  72. Assessing costs and benefits of incorporating family planning services delivery into a prepaid health maintenance organization plan in Brazil, CI 85.21A. Final report: AMICO Assistencia Medica, Sao Paulo, Brazil.
  73. Assessing the relationship among sex knowledge, contraceptive attitudes and practices and perceived need for family planning and sex education among selected Nigerian college students.
  74. Assessing the role of family planning in reducing maternal mortality.
  75. Assessment of knowledge of nurses working in family planning and maternity care about tubal sterilization and vasectomy.
  76. An assessment of procedures to detect contextual influences on fertility and contraception.
  77. Assessment of the technical and economic feasibility of manufacturing oral contraceptives in Zimbabwe.
  78. Assistance in family planning for employers in the private sector.
  79. The association of use of effective methods of contraception with fertility in Western countries.
  80. Attitudes about television, sex and contraception: a survey of a cross-section of adult Americans.
  81. Attitudes to family planning in Kenya: an anthropological approach.
  82. Attitudes towards contraception and some reasons for discontinuation. [La perception des contraceptifs et quelques donnees sur la discontinuation.]
  83. Attitudes towards family size and family planning among women at an antenatal clinic in Maiduguri, Nigeria.
  84. Atypical progressive stroke syndrome associated with oral contraceptives and cigarette use.
  85. The availability and accessibility of contraceptive services.
  86. Backgrounder on oral contraceptives.
  87. The Bangladesh experience in family planning and health.
  88. Barrier contraceptives and spermicides: their role in family planning care.
  89. Barriers to contraceptive services.
  90. Barriers to family planning service delivery in indigenous communities in Ecuador.
  91. Beneficial and undesired side-effects of oral contraceptives. [Gunstige Begleitwirkungen und unerwunschte Nebenwirkungen oraler Kontrazeptiva.]
  92. The benefits and risks of hormonal contraceptives: an epidemiologist's view.
  93. Better health for women and children through family planning; report of an International Conference held in Nairobi, Kenya, October 5-9, 1987.
  94. Better health through family planning. Recommendations of the International Conference on Better Health for Women and Children through Family Planning, Nairobi, October 1987.
  95. Biliary lipids, bile acid metabolism, gallbladder motor function and small intestinal transit during ingestion of a sub-fifty oral contraceptive.
  96. The biological basis for the contraceptive effects of breast feeding.
  97. Biologists and the promotion of birth control research, 1918-1938.
  98. Birth control and the concentration of fertility: a study of eleven European countries.
  99. Birth control policy, Provincial Party Committee and Provincial Government, 24 February 1987.
  100. Birth control practices of school-age mothers. Massachusetts Adolescent Pregnant and Parenting System.
  101. Birth control regulations, Fifth People's Conference, 17 May 1986.
  102. Birth control vaccines.
  103. Birth control X Family Planning in Brazil. [Controle da natalidade X Planejamento familiar no Brasil.]
  104. Birth control: family planning in Brazil. [Controle da natalidade: planejamento familiar no Brasil.]
  105. Birth order distribution as a family planning programme evaluation indicator. Phase II report.
  106. Black and Hispanic teenage sexual and contraceptive attitudes and behavior: a school-based study.
  107. Breast cancer and oral contraceptives.
  108. Breast-feeding, contraception and fertility.
  109. Breastfeeding and contraception: update.
  110. Breastfeeding women and family planning programs: special needs and opportunities.
  111. Brief annotations on recent ideas on contraception. [Breves anotaciones sobre recientes conceptos en anticoncepcion.]
  112. Bringing family planning into the orbit of spirit civilization through comprehensive tackling and with various services.
  113. Bringing family planning to the people in Sub-Saharan Africa.
  114. Broadcasting and family planning.
  115. Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranolol.
  116. Can natural family planning be successfully integrated into a public family planning program?
  117. Carcinoma of the breast and oral contraceptives. [Carcinom dojke i oralna kontraceptivna sredstva.]
  118. Cardiovascular diseases and hormonal contraceptives. [Kardiovaskulare Erkrankungen und hormonelle Kontrazeptiva.]
  119. A case study on the fertility and contraceptive practice of urban women. [Kent kadinlarinda dogurganlik ve gebelikten korunmaya iliskin bir ornek olay.]
  120. A case-control study of breast cancer and hormonal contraception in Costa Rica.
  121. The CBD programme of family planning services of Zaire (PRODEF)
  122. Cellular composition of cervical smears in relation to the day of the menstrual cycle and the method of contraception.
  123. Cerebral thromboembolism, oral contraceptives and pregnancy. [Cerebral tromboemboli, p-piller og graviditet.]
  124. Cerebrovascular deaths before and after the appearance of oral contraceptives.
  125. Cervical adenocarcinoma and oral contraceptives.
  126. Cervico-vaginal pathogens and contraception: microbiological observations. [Patogeni cervico-vaginali e contraccezione: osservazioni microbiologiche.]
  127. Cessation of childbearing in the absence of contraception in Sri Lanka.
  128. Changes in contraceptive use and sterilization acceptability.
  129. Changes in midwifery practice. 26. Postwar legislative guideline concerning family planning.
  130. Changes in the midwifery profession. 23. A process leading to legislation of family planning.
  131. Changes in the midwifery profession. 24. Pre-war birth control movements and the concept of eugenics.
  132. The characterization of sulphated metabolites of norethindrone in human milk after oral administration of contraceptive steroids.
  133. Chief complaints, contraceptive use and diagnoses of female soldiers in ambulatory GYN clinic.
  134. Child survival, fertility, and family planning in Africa. Uncertain prospects. [Survie des enfants, fecondite et planning familial en Afrique. Des perspectives peu certaines.]
  135. China's Family Planning Association demonstrates vigorous vitality.
  136. Chorea associated with oral contraception.
  137. Chorea induced by the use of oral contraceptive: report of a case and review of the literature.
  138. Chronic illness and contraception. [Krooniset sairaudet ja ehkaisy.]
  139. Circular on family planning, 11 July 1987.
  140. Circular on planned parenthood, 1987.
  141. Client-provider transactions in community-based family planning programs and the outreach component of clinic-based programs.
  142. Client-provider transactions in family planning clinics.
  143. Client-responsive family planning: a handbook for providers.
  144. Condoms replacing IUDs: integrated family planning with STD/AIDS.
  145. Consequences of contraceptive methods encountered in practice. [Ehkaisymenetelmien seuranta kaytannossa.]
  146. Consumer views and family planning perspectives. A survey of the Community Health Councils' assessment of local family planning needs together with a survey on the outlook of the regional health authorities in England and Wales.
  147. Continued contraceptive use in five family planning clinics in Surabaya, Indonesia.
  148. Contraception and changing images of sexuality: comments on Meredith Michaels' and Robert Solomon's reflections.
  149. Contraception and induced abortion. [La contraception et l'interruption volontaire de grossesse.]
  150. Contraception and lactation.
  151. Contraception and pregnancy in hereditary angioedema. [Kontrazeption und Schwangerschaft beim hereditaren Angioodem.]
  152. Contraception and pregnancy: study of comparative risks. [Kontrazeption und Schwangerschaft: versuch eines Risikovergleichs.]
  153. Contraception and sexuality. [Contraception et sexualite.]
  154. Contraception and the adolescent.
  155. Contraception and the Brazilian adolescent. [Anticoncepcao no adolescente Brasileiro.]
  156. Contraception and the skin. Review article.
  157. Contraception and the status of women: what is the link?
  158. Contraception at risk. [La contraception a risque.]
  159. Contraception by the progesterone antagonist RU 486: a novel approach to human fertility control.
  160. Contraception clinics in Denmark 1976-1985. [Antikonceptionsklinikker i Danmark 1976-1985.]
  161. Contraception during the postpartum period and during lactation: the effects on women's health.
  162. Contraception for American women 40 and over.
  163. Contraception for the perimenopausal patient.
  164. Contraception in adolescent girls: prevention. [Contraception de l'adolescente: prevention.]
  165. Contraception in adolescents and premenopausal women. [Empfangnisverhutung bei Jugendlichen und bei pramenopausalen Frauen.]
  166. Contraception in Brazil. [Anticoncepcao no Brasil.]
  167. Contraception in patients with heart disease. [Kontracepcija pri srcnih bolnicah.]
  168. Contraception in the first coitus. [Kontraception ved forste samleje.]
  169. Contraception in the future (editorial) [La contraception du futur.]
  170. Contraception in the populations of Baixa Renda: a qualitative study of attitudes, Brazil, 1985. [Anticoncepcao em populacoes de Baixa Renda: um estudo qualitativo de atitudes -- Brasil -- 1985.]
  171. Contraception in the year 2001.
  172. Contraception in young girls. A survey conducted in the MFPF Family Planning Center, Strasbourg in 1985. [Les jeunes filles et la contraception. Enquete realisee dans le centre de planification du MFPF a Strasbourg en 1985.]
  173. Contraception USA.
  174. Contraception using intrauterine devices: our experience with 564 cases. [La contraccezione con dispositivi intrauterini -- nostra esperienza su 564 casi.]
  175. Contraception, freedom and destiny: a womb of one's own.
  176. Contraception, pregnancy and breast feeding in the insulin-dependent diabetic.
  177. Contraception.
  178. Contraception: failure in practice.
  179. Contraception: potential manipulation of pathways normally used by environmental cues.
  180. Contraceptive and therapeutic applications of luteinizing hormone releasing hormone (LHRH) analogues.
  181. Contraceptive availability in the United States] [letter.
  182. Contraceptive behaviors among adolescent males attending a predominately black university --teaching and intervention strategies.
  183. Contraceptive choice [letter]
  184. Contraceptive choice [letter]
  185. Contraceptive choice [letter]
  186. Contraceptive choice [letter]
  187. Contraceptive choice and method switching in Malaysia.
  188. Contraceptive choice for women with chronic illnesses.
  189. Contraceptive choice in an urban clinic in Nigeria.
  190. Contraceptive choices: who, what, why.
  191. Contraceptive coils and their problems. [Kierukkaehkaisy ja sen ongelmat.]
  192. Contraceptive decision-making among adolescents.
  193. Contraceptive decision-making in the first year of sexual activity.
  194. The contraceptive development process and quality of care in reproductive health services, a meeting held in New York City October 8-9, 1986.
  195. The contraceptive ethos: reproductive rights and responsibilities.
  196. Contraceptive failure and discontinuation in Korea.
  197. Contraceptive failure in the United States: a critical review of the literature.
  198. Contraceptive failure in the United States: results from the 1982 National Survey of Family Growth.
  199. Contraceptive failure in the US.

     

  200. Contraceptive implants. [Implantes anticonceptivos.]
  201. Contraceptive method switching over women's reproductive careers.
  202. Contraceptive method switching over women's reproductive careers: evidence from Malaysia.
  203. Contraceptive methods and their effectiveness.
  204. Contraceptive methods, induced abortion, first sexual intercourse age, in a group of 1635 students of the University of Rome. [Contraccezione, I.V.G., eta del primo rapporto in un gruppo di studentesse dell'Universita di Roma.]
  205. Contraceptive methods. [Estemenetelmat.]
  206. Contraceptive mix in the Indonesian family planning program: causal modeling with time-series data from East Java.
  207. Contraceptive needs and practices among women attending an inner-city STD clinic.
  208. Contraceptive needs in the 21st century: a demographic analysis.
  209. Contraceptive needs in the Third World: the present paradox of a future family planning-technology nexus.
  210. Contraceptive practice in 209 diabetic women regularly attending a specialized diabetes clinic.
  211. Contraceptive practices and fertility among Southeast Asian, black, and white mothers attending a maternal infant care program.
  212. Contraceptive prevalence in Grenada.
  213. Contraceptive progestins and gonadotropin secretion in vitro.
  214. Contraceptive risk-takers: a study of personality and life event correlates.
  215. Contraceptive risk-taking behavior by sexually active adolescent females in the United States.
  216. A contraceptive service for men.
  217. Contraceptive services for ethnic minorities.
  218. Contraceptive social marketing in Nepal: consumer and retailer perspectives and experience.
  219. Contraceptive social marketing of Microgynon in the Dominican Republic -- progress of the campaign.
  220. Contraceptive social marketing training program.
  221. Contraceptive social marketing vs. specialized community-based distribution programs in Colombia.
  222. Contraceptive social marketing.
  223. Contraceptive sterilization: a multivariate analysis of United States data.
  224. Contraceptive steroids increase cholesterol in bile: mechanisms of action.
  225. Contraceptive steroids. Preface. [Empfangnisverhutung mit Steroiden: Vorbemerkungen.]
  226. Contraceptive studies with luteinizing hormone-releasing hormone agonists.
  227. Contraceptive switching among currently married women in the United States.
  228. Contraceptive technology and safety.
  229. Contraceptive technology and the law.
  230. Contraceptive usage during lactation in the United States: an update.
  231. Contraceptive use among high-risk adolescents.
  232. Contraceptive use among Turkish and Moroccan immigrants in the Netherlands.
  233. Contraceptive use during lactation in developing countries.
  234. Contraceptive use patterns in Matlab, Bangladesh: insights from a 1984 survey.
  235. Contraceptives for the twenty-first century.
  236. Coping style as a determinant of contraceptive behavior.
  237. Copper - a major contraceptive agent? [Le cuivre, agent contraceptif majeur?]
  238. The Copper T 380A IUD: expanding contraceptive options. Excerpts.
  239. Correcting survey-based contraceptive failure rates for abortion under-reporting.
  240. Correctly understand and use the measures of progress of the family planning program.
  241. Cost effectiveness of the APROFAM program for voluntary surgical contraception in Guatemala.
  242. Cost recovery in family planning.
  243. Cost-benefit analysis of the family planning program of the Instituto Mexicano del Seguro Social (economic impact) [Analisis del costo beneficio del programa de planificacion familiar del Instituto Mexicano del Seguro Social (impacto economico)]
  244. A cost-benefit analysis of the Mexican Social Security Administration's family planning program. Summary.
  245. Couples and the male birth control pill: a future alternative in contraceptive selection.
  246. Create positive contraceptive images for strongest impact in single lesson.
  247. Creating a male contraceptive service.
  248. Criteria for conducting surveys and for contraceptive use in Brazil. [Criterios para a conducao de pesquisas e para a utilizacao de contraceptivos no Brasil.]
  249. Crown Order of 27 February 1987 amending the Crown Order of 9 July 1973 on Contraceptives.
  250. Cultural notions of fertility in South Asia and their impact on Sri Lankan family planning practices.
  251. Cultural perspectives on contraceptive technology.
  252. Current evaluation of risk of tumors from oral contraception. [Gegenwartiger Stand des Tumorrisikos bei der oralen Kontrazeption.]
  253. The current status of family planning as a component of CBHC / FP projects in Kenya.
  254. Current status of male contraceptive operations --questionnaire at vasectomy.
  255. Cytologic and histologic changes in the endometrium in intrauterine contraception users having experienced bleeding. [Citoloske i histoloske promene endometrijuma kod korisnika intrauterine kontracepcije koje su pracene krvavljenjem.]
  256. Danish pharmacies give "straight facts about contraception".
  257. Decision on family planning, 7 January 1987.
  258. Decision on Some Policies for Stronger Development of the Implementation of Family Planning, Council of Ministers, 15 September 1986.
  259. The demand for family planning.
  260. Demographic characteristics of family planning acceptors and their implications: state-wise analysis--India, 1979-81.
  261. Demographic impact of family planning in Mexico. [Impacto demografico de la planificacion familiar en Mexico.]
  262. Demographic structure, contraception and utilization of maternal and child health care services in a district of Uttar Pradesh. (Report on the study of Bahraich District)
  263. Demographic, individual difference, and social variables related to contraceptive use by young, male, college students.
  264. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
  265. Determinant analysis on contraceptive use and efficiency of family planning program performance. [Analisis determinan pemakaian kontrasepsi dan efisiensi pelaksanaan program keluarga berencana.]
  266. The determinants of changes in contraceptive status: the case of Bohol, Philippines.
  267. Determinants of contraceptive use in rural Bangladesh: the demand for children, supply of children, and costs of fertility regulation.
  268. Determinants of family planning acceptance in India and Uttar Pradesh.
  269. Determinants of family planning acceptance in India.
  270. The determinants of family planning program effectiveness.
  271. Developing company-based family planning services. A module for use by trainers in workshops for managers. Draft.
  272. The development of modern contraceptive technology.
  273. Development of project proposal for the Egyptian Family Planning Association, a trip report.
  274. Developments in new progestagens for oral contraception.
  275. A different single life table approach to study the dynamics of contraceptive use.
  276. Different types of organisations involved in providing family planning services in Nigeria.
  277. Differential fertility and contraceptive prevalence rate in Korea.
  278. Differentials in current contraceptive use at the regional level, Egypt, 1984.
  279. Differentials in fertility and contraceptive behavior in Sri Lanka: the ethno-religious factor.
  280. Dilatation of the sinusoids in liver tissue caused by oral contraceptives. Electron microscopy studies in 14 cases of surgical liver excision. [Sinusoidok dilatatioja a majszovetben, oralis antikoncipiens szerek szedesevel kapcsolatban: 14 sebeszeti majexcizio elektronmikroszkipos vizsgalata.]
  281. Direct effects of family planning on adolescent health.
  282. Distance and continuation rates in a family planning clinic: a case study from Jamaica.
  283. Distribution of contraceptives in factories in St. Lucia.
  284. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone.
  285. Do oral contraceptives increase the risk of developing cholelithiasis? [Zvysuju peroralne kontraceptiva riziko vzniku cholelitiaz?]
  286. Do plain plastic and copper bearing intrauterine contraceptive devices have a central mechanism of action?
  287. Do women using oral contraceptive agents require extra zinc?
  288. Does family planning reduce infant mortality rates?
  289. Does family planning save children's lives?
  290. Does the use of oral contraception depress DZ twinning rates?
  291. Dominican Republic: Contraceptive Social Marketing Project.
  292. Drug regulation, product liability, and the contraceptive crunch.
  293. The duration of contraceptive protection by copper intrauterine devices. [Trajanje kontracepcijske zastite intrauterinim uloscima s dodatkom bakra.]
  294. Early oral contraceptive use and breast cancer: results of another case-control study.
  295. Economic aspects of Singapore's selective family planning policy.
  296. An economic evaluation of recent changes in Singapore's family planning program.
  297. The economic rationale of family planning programs.
  298. Economics and fertility: a popular review related to family planning programs. [Ekonomi dan fertilitas: suatu pembahasan populer sekitar program keluarga berencana.]
  299. Education, fertility and family planning practices in a rural area of Bangladesh.
  300. Effect of an intrauterine contraceptive device on the endometrium and gonadotropin levels in the peripheral blood. [Wplyw wkladki wewnatrzmacicznej na blone sluzowa macicy oraz stezenie gonadotropin w krwi obwodowej.]
  301. The effect of contraceptive technology on the program environment.
  302. Effect of contraceptives on the adhesion of Escherichia coli to uroepithelial cells.
  303. The effect of exercise and oral contraceptives on total serum calcium, estradiol and luteinizing hormone in moderately trained women.
  304. Effect of family planning availability and accessibility on contraceptive use in Nepal.
  305. The effect of intrauterine contraceptive devices on the endometrium. [Effet des dispositifs intra-uterins sur l'endometre.]
  306. Effect of long-term oral contraception on the risk factors of coronary heart disease.
  307. Effect of nuptiality, contraception and breast-feeding on fertility in Bangladesh.
  308. The effect of oral contraceptive acceptance on fertility in the postpartum period.
  309. The effect of oral contraceptive pills on levels of oxytocin in plasma and on cognitive functions.
  310. Effect of oral contraceptives on the ultrastructure of the endometrium.
  311. Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism.
  312. The effect of sex preference on fertility and family planning: empirical evidence.
  313. Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis: a comparative trial.
  314. Effect of the hormonal contraception on serum reverse triiodothyronine levels.
  315. Effect of the Today contraceptive sponge on growth and toxic shock syndrome toxin-1 production by Staphylococcus aureus.
  316. The effect of two low-dose contraceptives containing ethinylestradiol and desogestrel or d-norgestrel on blood clotting factors.
  317. The effect of two steroid contraceptives on the function of rRNA genes of users.
  318. The effect of village modernization and the family planning and nutrition program on household knowledge and behavior in East Java and Bali, Indonesia.
  319. Effective communication breaks through socio-cultural barriers in family planning: the Sri Lankan experience.
  320. Effectiveness of individual family planning measures in the Democratic Republic of Afghanistan. [Effectivnost otdelnykh meropriiatii po planirovaniiu semi v Demokraticheskoi Respublike Afghanistan.]
  321. Effects of a very low-estrogen oral contraceptive on clotting factors, carbohydrate metabolism and plasma lipids and lipoproteins.
  322. The effects of contraceptive use on the initiation and duration of lactation.
  323. The effects of family planning on fertility: research findings.
  324. The effects of family planning on improving efficiency and effectiveness of health services.
  325. The effects of hormonal and non-hormonal contraceptives on human lactation and on the re-establishment of fertility.
  326. The effects of negative emotional orientation to sex on birth control information retention and use.
  327. Effects of oral contraceptives on liver function and structure. [Auswirkungen oraler Kontrazeptiva auf Leberfunktion und -struktur.]
  328. The effects of oral contraceptives on mood and sexuality: a comparison of triphasic and combined preparations.
  329. The effects of oral contraceptives on therapeutic drugs.
  330. Effects of serum from oral contraceptive users on the metabolism of low density lipoprotein.
  331. Effects of the oral contraceptive pill on mood and sexual behaviour.
  332. Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems.
  333. Effects on hearing during prolonged oral contraceptive use.
  334. Efficacy of low-dose oral contraceptives containing levonorgestrel, gestoden and cyproterone acetate.
  335. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
  336. Eikenella corrodens and intrauterine contraceptive device [letter]
  337. Emotional and cognitive barriers to effective contraception: are males and females really different?
  338. Emotions, attitudes, normative beliefs, and behavior regarding contraceptive use and abortion status.
  339. Encouragement of the national family planning program in Rwanda. [Encouragement du programme national de planning familial au Rwanda.]
  340. Epidemiological characteristics of the acquired immunodeficiency syndrome (AIDS) in connection with the activities of maternal health care and family planning services. [Niakoi epidemiologichni osobenosti na sindroma na pridobitata imunna nedostatuchnost (SPIN) vuv vruzka s deinostta na sluzhbite za maichino zdraveopazvane i semeino planirane.]
  341. Epidemiology of contraception with steroids in Western Europe.
  342. Establishment of a contraceptive distribution and invoicing system for pharmacists in Tunisia. [Etablissement d'un systeme de distribution et facturation de contraceptif aux pharmaciens en Tunisie.]
  343. The establishment of family planning clinics in south-west Nigeria by 1970: analyses using logit and Poisson regression.
  344. Estimation of a microeconomic model of contraceptive use in rural Mexico.
  345. Estrogens for contraception. [Ostrogene zur Empfangnisverhutung.]
  346. Ethical issues in providing family planning within primary health care.
  347. Ethics of family planning.
  348. Ethiopia moves cautiously on family planning.
  349. Ethno-religious differentials in contraceptive accessibility and use in Sri Lanka.
  350. Evaluating the health risks and benefits of birth control methods.
  351. Evaluation of an oral contraceptive containing 0.150 mg desogestrel and 0.020 mg ethinylestradiol in women aged 30 years or older.
  352. An evaluation of contraceptive knowledge and practice in an urban community in Benin City in Nigeria.
  353. Evaluation of Copper T-200 as a post-coital contraceptive.
  354. An evaluation of family planning programme in Shanghai County.
  355. Evaluation of some coagulation tests in women using low dosage oral contraception. [Valutazione di alcuni test della coagulazione in donne che usano contraccettivi orali a basso dosaggio.]
  356. Evaluation of the Norplant contraceptive in the city of Rio de Janeiro, RJ, Brazil. [Avaliacao do anticoncepcional Norplant no municipio do Rio de Janeiro, RJ (Brasil)]
  357. Evaluation of Village Family Planning Program, USAID Indonesia Project: 497-0327, 1983-1986.
  358. Evolution of the national family planning program in Morocco. [Evolution du programme national de planification familiale au Maroc.]
  359. An examination of hypermasculinity and contraceptive use and attitudes in adolescent males.
  360. Expanding quality family planning services in Francophone Africa.
  361. Experience with injectable contraceptives in Thailand.
  362. Exposure to contraceptive hormones through breast milk -- are there long-term health and behavioral consequences?
  363. Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral-contraceptive use.
  364. Factors affecting acceptability of long-acting contraceptive injections in a rural Egyptian community.
  365. Factors affecting the use of contraception in urban areas of Indonesia.
  366. Factors influencing the decision to choose voluntary surgical contraception: results from six surveys.
  367. Family and family planning in Southern Ghana.
  368. Family grasping establishment of service net, making family planning work become a regular practice and a system.
  369. Family planning / child spacing objectives and activities.
  370. Family planning accessibility and adoption: the Korean population policy and program evaluation study.
  371. Family planning accessibility and practices; a local survey of family physicians.
  372. Family planning activities and the role of the Ethiopian mass media.
  373. Family planning and contraceptive responsibility.
  374. Family planning and ideology: concepts and conceptions. [Planificacion familiar e ideologia: conceptos y concepciones.]
  375. Family planning and majority acceptance. [Planejamento familiar e aceito pela maioria.]
  376. Family planning and maternal health. [Planificacion familiar y salud materna.]
  377. Family planning and reproductive risks: international and Brazilian experiences. [Planejamento familiar e os riscos reprodutivos: experiencias internacionais e brasileiras.]
  378. Family planning and the health of women and children.
  379. Family planning and the private sector.
  380. Family planning and women's health: a view from Africa.
  381. Family planning as a primary health care.

     

  382. Family planning as a solution? On the public health system in Tunisia. [Ausweg Familienplanung? Zum staatlichen Gesundheitswesen in Tunesien.]
  383. Family Planning Association of Kenya (FPAK), voluntary surgical contraception program.
  384. Family Planning Association of Kenya community-based distribution of contraceptives pilot project.
  385. The Family Planning Association of Queensland. The 1987 Play Safe - One-on-One campaign.
  386. Family planning behaviour in Maharashtra.
  387. Family planning by and for market women: preliminary results of an operations research project in Lima, Peru.
  388. Family planning can reduce maternal mortality. [La planificacion familiar puede reducir la mortalidad materna.]
  389. Family planning carried out in line with actual conditions in national minority areas.
  390. The family planning clinic in Africa, a practical guide for contraception clinic professionals.
  391. A family planning clinic in the factory.
  392. Family planning consultations during antenatal and postnatal care. The role of the midwife and health worker.
  393. Family planning development and services II project (398-0249): Indonesia: an urban sector strategy.
  394. Family planning for inner-city adolescent males: pilot study.
  395. Family planning for mentally handicapped girls.
  396. Family planning for the mentally ill and handicapped.
  397. Family Planning Foundation.
  398. Family planning from Bucharest to Mexico.
  399. Family planning in a changing world: an IPPF reappraisal.
  400. Family planning in aboriginal communities.
  401. Family planning in Africa: toward responsible parenthood. An annotated bibliography. [La regulation des naissances en Afrique: pour une parente responsable. Bibliographie commentee.]
  402. Family planning in Colombia -- 1987. [La planificacion familiar en Colombia -- 1987.]
  403. Family planning in Cuba. [Planejamento familiar em Cuba.]
  404. Family planning in Indian industries--a status paper.
  405. Family planning in rural Kwazulu: transition from traditional to contemporary practices.
  406. Family planning in the 1990's: the unfinished demographic transition.
  407. Family planning in the workplace in Jamaica.
  408. Family planning in Tunisia: reasons for its success and future strategy. [La planification familiale en Tunisie: raisons d'un succes et strategie du futur.]
  409. Family planning in Tunisia: reasons for success and strategies for the future. [La planification familiale en Tunisie: raisons d'un succes et strategie du futur.]
  410. Family planning in Venezuela. [La planificacion familiar en Venezuela.]
  411. Family planning in Viet Nam. [La planification familiale au Viet-Nam.]
  412. Family planning in Vietnam. [La planification familiale au Viet-Nam.]
  413. Family planning management training: case study evaluation in Senegal.
  414. Family planning measures, 1987.
  415. Family planning methods: safety, choice and delivery in the primary health care context.
  416. Family planning needs and behavior of Mexican American women: a study of health care professionals and their clientele.
  417. Family planning needs help to reduce the number of abortions. [La planificacion familiar necesita ayuda para reducir el numero de abortos.]
  418. Family planning needs of the urban slums and remote rural areas in the Republic of Korea.
  419. Family planning on wheels: costs and benefits of a mobile delivery system compared to the traditional clinic.
  420. Family planning policies and guidelines.
  421. Family planning policies, development planning, and the challenge to non-governmental organizations.
  422. Family planning policy action plan for the Federal Capital Territory, Abuja.
  423. Family planning program in Bangladesh.
  424. Family planning program resources: focus on funds.
  425. A family planning program that pays for itself.
  426. Family planning programme at Godrej--sharing of experience.
  427. Family planning programme in India (its impact in rural and urban areas--1970-1980)
  428. Family planning programme in India: an economic evaluation.
  429. Family planning programme news.
  430. Family planning programme: role of services.
  431. Family planning programs for the Arab World Region.
  432. Family planning programs.
  433. Family Planning Regulations, Provincial People's Congress Standing Committee, 2 July 1987.
  434. Family planning services for men: the role of federal regulation.
  435. Family planning services in traditional markets in Nigeria.
  436. Family planning services.
  437. Family planning standards. [Normas de planificacion familiar.]
  438. Family planning statistics, 1986. [Statistiques de planning familial, 1986.]
  439. Family planning takes off in Pakistan.
  440. Family Planning Title X, under attack again.
  441. Family planning utilization by black and white women: public health social work implications.
  442. Family planning within primary health care.
  443. Family planning, breastfeeding, and pregnancy among urban Filipino women.
  444. Family planning.
  445. Family planning.
  446. Family planning. A document prepared for nurses, midwives, social workers, teachers.
  447. Family planning: India's Achilles' heel?
  448. Family planning: results of a survey in a rural environment. [Planificacion familiar: resultados de una encuesta en el medio rural.]
  449. Family planning: an essential ingredient of family health.
  450. Family planning: changed emphasis.
  451. Family planning: the impact on the health of women and children.
  452. Family structure, salience, and knowledge of family planning methods among urban Kenyans.
  453. FDA revises guidelines for oral contraceptive labeling.
  454. Female contraception: possible endocrine approaches.
  455. Female steroidal contraception. Preface. [Empfangnisverhutung mit Steroiden. Vorbemerkungen.]
  456. Female surgical contraception at the University of Ilorin Teaching Hospital, Ilorin, Nigeria.
  457. Fertility and contraception in Maghreb. [Fecondite et contraception au Maghreb.]
  458. Fertility and family planning in Papua New Guinea, a comment.
  459. Fertility and family planning in rural areas (a longitudinal study)
  460. Fertility and family planning in the Dakshina Kannada district, Karnataka, India.
  461. Fertility and family planning. [Fecondite et planification de la famille.]
  462. Fertility awareness / natural family planning for adolescents and their families: report of multisite pilot project.
  463. Fertility decline and contraceptive use in a rural area of Kenya.
  464. Fertility following ectopic pregnancy with special reference to previous use of an intra-uterine contraceptive device (IUCD)
  465. Fertility, development, and family planning, 1970-1980: an analysis of cases weighted by population.
  466. Fertility, mortality and contraceptive prevalence in the Dangs.
  467. Final protocol: prospective study to compare four randomly allocated low dose monophasic oral contraceptives.
  468. Final report of the study: "Adolescents in Mexico City: psychosocial study of contraceptive practices and unwanted pregnancy". Conclusions and recommendations. [Reporte final de la investigacion: "Adolescentes en la Ciudad de Mexico: Estudio Psicosocial de las Practicas Anticonceptivas y Embarazo no Deseado". Conclusiones y recomendaciones.]
  469. Final report summary, Population Communication Services, Johns Hopkins University, Project LA-BRA-01. Associacao Brasileira de Entidades de Planejamento Familiar (ABEPF), Family Planning IEC Activities.
  470. Final report: AF-NGA-02. Family Planning Method Pictorial Booklets Production and Distribution: a first in contraceptive print materials for low-literate clients in Nigeria.
  471. Final report: women from six countries who elected surgical contraception: factors influencing their decision.
  472. The First African Conference on the Integrated Project with Family Planning, Nutrition and Parasite Control, PANFRICO-I, 2-9 March 1987, Arusha, Tanzania: proceedings.
  473. First intercourse, contraception and first pregnancy in Flanders: changes during the past 30 years.
  474. First Peruvian and First Latin American Congress on Family Planning. Conclusions. Recommendations. [I Congreso Peruano y I Congreso Latinoamericano de Planificacion Familiar. Conclusiones. Recomendaciones.]
  475. Fodder trees and family planning in Nepal.
  476. Follow-up of adolescents previously studied for contraceptive compliance.
  477. Follow-up report: CORAT-sponsored conference on community-based health care and family planning.
  478. For an integration of family planning education in the organized sector: the Tunisian experience.
  479. Foreign trip report (AID/RSSA): Paraguay, August 23-29, 1987 -- Family Planning Survey [memorandum]
  480. Fostering social change is the key to increasing contraceptive prevalence.
  481. The FPOP experience in family planning and women's development--the Philippine overview.
  482. Fragmentation and reproductive freedom: federally subsidized family planning services, 1960-80.
  483. Function of the kidneys and the renin-aldosterone system in women before and after use of intrauterine contraceptive devices. [Funktsionalnoe sostoianiia pochek i sistemy renin-aldosteron u zhenshchin do i posle primeneniia vnutrimatochnykh kontratseptivov.]
  484. Funding contraceptive development.
  485. The future of contraceptive technology.
  486. The future of intrauterine contraception.
  487. The future of steroids in female contraception.
  488. Future prospects in male contraception.
  489. Gaps in knowledge, skills and practices of health and family planning personnel.
  490. Generic barriers to the acceptance of family planning in Nigeria.
  491. Genital ulcers and oral contraceptives facilitate male-female transmission of HIV.
  492. Gestoden: clinical experience with a new biphasic and triphasic contraceptive [gestoden delta 15-levonorgestrel and ethinylestradiol. [Gestoden: experiencia clinica con un nuevo anticonceptivo bifasico y trifasico (gestoden, delta 15-levonorgestrel y etinilestradiol]]
  493. The Ghanaian woman: development through education and family planning.
  494. Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes.
  495. Guidelines for the toxicological and clinical assessment and post-registration surveillance of steroidal contraceptive drugs.
  496. Guidelines No. 100 on the provision of information concerning contraceptive methods, 8 September 1986.
  497. Guidelines on psychosocial problems of family planning clients.
  498. Has family planning a future?
  499. Has she or hasn't she? U.S. women's experience with contraception.
  500. Health aspects of family planning: the evidence from Africa.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.